Barak Y, et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell. 1999;4(4):585–95.PubMedCrossRef

Berger H, et al. SOCS3 transactivation by PPARgamma prevents IL-17-driven cancer growth. Cancer Res. 2013;73(12):3578–90.PubMedCrossRef

Bhagavathula N, et al. Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes. J Invest Dermatol. 2004;122(1):130–9.PubMedCrossRef

Bongartz T, et al. Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study. Rheumatology. 2005;44(1):126–9.PubMedCrossRef

Botton T, et al. In vitro and in vivo anti-melanoma effects of ciglitazone. J Invest Dermatol. 2009;129(5):1208–18.PubMedCrossRef

Braissant O, et al. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology. 1996;137(1):354–66.PubMed

Chene G, et al. n-3 and n-6 polyunsaturated fatty acids induce the expression of COX-2 via PPARgamma activation in human keratinocyte HaCaT cells. Biochim Biophys Acta. 2007;1771(5):576–89.PubMedCrossRef

Dai X, et al. STAT5a/PPARgamma pathway regulates involucrin expression in keratinocyte differentiation. J Invest Dermatol. 2007;127(7):1728–35.PubMed

Dai X, et al. PPAR gamma is an important transcription factor in 1 alpha, 25-dihydroxyvitamin D3-induced involucrin expression. J Dermatol Sci. 2008;50(1):53–60.PubMedCrossRef

Dai X, et al. PPARgamma mediates innate immunity by regulating the 1alpha, 25-dihydroxyvitamin D3 induced hBD-3 and cathelicidin in human keratinocytes. J Dermatol Sci. 2010;60(3):179–86.PubMedCrossRef

Demerjian M, et al. Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-gamma, normalizes epidermal homeostasis in a murine hyperproliferative disease model. Exp Dermatol. 2006;15(3):154–60.PubMedCrossRef

Desreumaux P, et al. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. J Exp Med. 2001;193(7):827–38.PubMedCentralPubMedCrossRef

Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev. 1999;20(5):649–88.PubMed

Di-Poi N, et al. Functions of peroxisome proliferator-activated receptors (PPAR) in skin homeostasis. Lipids. 2004;39(11):1093–9.PubMedCrossRef

Downie MM, et al. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro. Br J Dermatol. 2004;151(4):766–75.PubMedCrossRef

Eastham LL, Mills CN, Niles RM. PPARalpha/gamma expression and activity in mouse and human melanocytes and melanoma cells. Pharm Res. 2008;25(6):1327–33.PubMedCrossRef

Ellis CN, et al. Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation. Arch Dermatol. 2000;136(5):609–16.PubMedCrossRef

Ellis CN, et al. Placebo response in two long-term randomized psoriasis studies that were negative for rosiglitazone. Am J Clin Dermatol. 2007;8(2):93–102.PubMedCrossRef

Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol. 2007;127(3):514–25.PubMedCrossRef

Fang F, et al. The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy. Arthritis Res Ther. 2012;14(5):R229.PubMedCentralPubMedCrossRef

Feingold KR, Elias PM. Role of lipids in the formation and maintenance of the cutaneous permeability barrier. Biochim Biophys Acta. 2014;1841(3):280–94.PubMedCrossRef

Festa E, et al. Adipocyte lineage cells contribute to the skin stem cell niche to drive hair cycling. Cell. 2011;146(5):761–71.PubMedCentralPubMedCrossRef

Flori E, et al. 2,4,6-Octatrienoic acid is a novel promoter of melanogenesis and antioxidant defence in normal human melanocytes via PPAR-gamma activation. Pigment Cell Melanoma Res. 2011;24(4):618–30.PubMedCrossRef

Fu G, et al. Committed differentiation of hair follicle bulge cells into sebocytes: an in vitro study. Int J Dermatol. 2010;49(2):135–40.PubMedCrossRef

Ghosh AK, et al. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma. Arthritis Rheum. 2004;50(4):1305–18.PubMedCrossRef

Ghosh AK, et al. Peroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator. FASEB J. 2009;23(9):2968–77.PubMedCentralPubMedCrossRef

Gonzalez EG, et al. Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis. Ann Rheum Dis. 2012;71(9):1545–51.PubMedCrossRef

Grabacka M, et al. PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91. Pigment Cell Melanoma Res. 2008;21(3):388–96.PubMedCentralPubMedCrossRef